Patent 7067493 Issued on June 27, 2006. Estimated Expiration Date: June 29, 2025. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
514/29, The hetero ring has exactly 13 ring carbons (e.g., erythromycin, etc.)514/459, Nitrogen containing424/483, Ion-exchange resins435/6Involving nucleic acid
The present invention relates to a method of treating infections in humans by administering a single dose of azithromycin.
Other References
Block et al., “Single Dose Azithromycin (30 mg/kg) in Acute Otitis Media”, 38th Annual Meeting of the Infectious Disease Society of America, New Orleans, La., Sep. 7-10, 2000.
Schonwald, S., et al., Infection, Germany, vol. 27, No. 3, May 1999, pp. 198-202 XP008018295.
Amsden, G.W., et al., The J. of Antimicrobial Chemotherapy, 47(1), pp. 61-66 (2001) XP001159703.
Block, S., et al., 38th Annual Meeting of the Infectious Diseases Society of America, New Orleans, LA, Sep. 7-10, 2000, Single-Sose Azithromycin (30mg/kg) in Acute Otitis Media, Abstract 174.
Muller O., The J. of Antimicrobial Chemotherapy, England, Jun. 1993, vol. 31, suppl. E, Jun. 1993, pp. 137-146 XP008018300.
Nightingale C.H., et al., J. of Infectious Disease Pharmacotherapy 1999, vol. 4, No. 1, pp. 17-24 XP008018297.
Aoki N., Japanese Journal of Chemotherapy 1995, Japan, vol. 43, No. Suppl 6, pp. 234-238 XP008018296.
Morris, D.L., et al., vol. 10, No. 10., Oct. 1991, pp. 859-861, European J. of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology, Germany XP008018299.
Klepser, M., et al., International J. of Antimicrobial Agents, vol. 17, No. Supp 1, Jun. 2001, p. S157, 22nd International Congress of Chemotherapy; Amsterdam, Jun. 30-Jul. 3, 2001 XP002244592.
Law et al., The Annals of Pharmacotherapy, vol. 38, pp. 433-439, Mar., 2004, “Single-Dose Azithromycin for Respiratory Tract Infections”.
Arguedas, A., Single-Dose Therapy In Otitis Media, Poster Presentation at 9th European Congress of Clinical Microbiology and Infectious Diseases, Berlin, Germany, Mar. 21-24, 1999, Clin. Microbiol. Infect. 1999:5 (Supp. 3 Mar.):28 (Abstr).
P/S/L Consulting Group Inc., Single-Dose Zithromax (Azithromycin) as Effective as 10 Days of Augmentin (Amoxcillin/Clavulenate) for Otitis Media, Doctor's Guide; Sep. 14, 2000.
FDA Briefing Package: Zithromax® (Azithromycin) Oral Suspension Single-Dose and Three Day Treatment of Acute Otitis Media, Anti-Infective Drugs Advisory Committee, Nov. 7, 2001.
June 29, 2025. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
